FDA Clarifies Stance on Clinical Trial Reimbursements

International Pharmaceutical Regulatory Monitor
A A
The FDA updated its guidance to institutional review boards and clinical investigators, detailing its views on reimbursements for lodging and travel for clinical trial participants.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor